- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT03665818
The Influence of Mandibular Advancement Device Treating OSAHS on Primary Prevention of Ischemic Stroke
- The purpose of this study is to detect the differences of carotid atherosclerosis severity between patients with or without OSAHS(Obstructive Sleep Apnea and Hypopnea Syndrome) in a cross-sectional study in a large sample.
- Then a longitudinal control study is conducted to observe the progress of the carotid atherosclerosis by vascular ultrasonography and the occurrence of cerebrovascular events after the intervention of the oral appliance for treating OSAHS,and finally explore the feasibility of using oral appliance to treat OSAHS in primary prevention of ischemic stroke.
Обзор исследования
Статус
Вмешательство/лечение
Подробное описание
- the relevance of OSAHS and carotid atherosclerosis Patients are distributed questionnaire and recruited from neurology clinic,vascular ultrasonography clinic of Xuanwu Hospital if they match the inclusion criteria. After initial screening, carotid atherosclerosis patients with skeptical OSAHS are sent to sleep center for polysomnography examination to determine the severity of OSAHS. At least 50 patients for mild, moderate, severe OSAHS each are recruited for OSAHS Group. At least 100 patients without snoring from questionnaire and without OSAHS after PSG screening are recruited for non OSAHS Group. Vascular ultrasonography examination for carotid are done for the two groups. Data of carotid vascular plaque from two groups are collected. Statistics are done to detect differences of carotid atherosclerosis severity between patients with and without OSAHS, also the severity of OSAHS.
- the relevance of the progress of carotid atherosclerosis and oral appliances intervention for treating OSAHS All carotid atherosclerosis patients with OSAHS are from patients of the first study. If they consent the treatment of oral appliances, they are recruited into this second study. At least 100 patients are recruited. They are divided into 2 groups by randomized block design by Evidence-based Medicine Center of Xuanwu Hospital. One group is oral appliance intervention group, the other group is no intervention group. The intervention group patients accept oral appliance treatment, and no intervention group patients do not accept OSAHS treatment. The two groups both accept anti-hypertension treatment or anti-diabetes treatment, or anti-hyperlipidemia treatment according to their own situation in neurology clinic.
At timepoint of initial time, one month after oral appliance treatment, one and a half year after oral appliance treatment, the intervention group should accept PSG(Polysomnography) examination to monitor the treatment of OSAHS.
At timepoint of initial time, one month after oral appliance treatment, one and a half year after oral appliance treatment, the two groups should accept breath holding test to monitor the cerebral vascular reserve.
At timepoint of initial time, one and a half year after oral appliance treatment, the two groups should accept carotid vascular ultrasonography examination to monitor the progress of carotid atherosclerosis.
Cerebrovascular events and death are recorded from initial time. Statistics are done to detect the influence of treatment of OSAHS on carotid atherosclerosis.
Тип исследования
Регистрация (Ожидаемый)
Фаза
- Непригодный
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Ребенок
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- diagnosed with atherosclerosis by vascular ultrasonography
- diagnosed with OSAHS by polysomnography
Exclusion Criteria:
- patients who have stroke already
- patients who can not wear oral appliances according to experiment requirements
- patients who have bad periodontal condition or teeth number less than 20
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
---|---|
Экспериментальный: Oral appliance intervention
|
mandibular advancement device to enlarge pharyngeal airway space to get rid of apnea and hypopnea events
|
Без вмешательства: Without oral appliance intervention
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
---|---|---|
apnea hypopnea events 0 in Times
Временное ограничение: initial time when patients are recruited
|
apnea and hypopnea times per hour
|
initial time when patients are recruited
|
apnea hypopnea events 1 in Times
Временное ограничение: one month after oral appliance treatment
|
apnea and hypopnea times per hour
|
one month after oral appliance treatment
|
apnea hypopnea events 2 in Times
Временное ограничение: one and a half years after oral appliance treatment
|
apnea and hypopnea times per hour
|
one and a half years after oral appliance treatment
|
longest apnea time 0 in Seconds
Временное ограничение: initial time when patients are recruited
|
longest apnea or hypopnea time
|
initial time when patients are recruited
|
longest apnea time 1 in Seconds
Временное ограничение: one month after oral appliance treatment
|
longest apnea or hypopnea time
|
one month after oral appliance treatment
|
longest apnea time 2 in Seconds
Временное ограничение: one and a half years after oral appliance treatment
|
longest apnea or hypopnea time
|
one and a half years after oral appliance treatment
|
Blood oxygen saturation less than 90% of the total monitoring time percentage 0 in percentage
Временное ограничение: initial time when patients are recruited
|
Blood oxygen saturation less than 90% of the total monitoring time percentage
|
initial time when patients are recruited
|
Blood oxygen saturation less than 90% of the total monitoring time percentage 1 in percentage
Временное ограничение: one month after oral appliance treatment
|
Blood oxygen saturation less than 90% of the total monitoring time percentage
|
one month after oral appliance treatment
|
Blood oxygen saturation less than 90% of the total monitoring time percentage 2 in percentage
Временное ограничение: one and a half years after oral appliance treatment
|
Blood oxygen saturation less than 90% of the total monitoring time percentage
|
one and a half years after oral appliance treatment
|
lowest Oxygen Saturation 0 in percentage
Временное ограничение: initial time when patients are recruited
|
blood lowest oxygen saturation during the whole night
|
initial time when patients are recruited
|
lowest Oxygen Saturation 1 in percentage
Временное ограничение: one month after oral appliance treatment
|
blood lowest oxygen saturation during the whole night
|
one month after oral appliance treatment
|
lowest Oxygen Saturation 2 in percentage
Временное ограничение: one and a half years after oral appliance treatment
|
blood lowest oxygen saturation during the whole night
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness 0 in common carotid artery in milimetre
Временное ограничение: initial time when patients are recruited
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
initial time when patients are recruited
|
atherosclerosis plaque thickness 1 in common carotid artery in milimetre
Временное ограничение: one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque length 0 in common carotid artery in milimetre
Временное ограничение: initial time when patients are recruited
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
initial time when patients are recruited
|
atherosclerosis plaque length 1 in common carotid artery in milimetre
Временное ограничение: one and a half years after oral appliance treatment
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaqu
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness 0 in internal carotid artery in milimetre
Временное ограничение: initial time when patients are recruited
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
initial time when patients are recruited
|
atherosclerosis plaque thickness 1 in internal carotid artery in milimetre
Временное ограничение: one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness 0 in carotid bulb in milimetre
Временное ограничение: initial time when patients are recruited
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
initial time when patients are recruited
|
atherosclerosis plaque thickness 1 in carotid bulb in milimetre
Временное ограничение: one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque length 0 in internal carotid artery in milimetre
Временное ограничение: initial time when patients are recruited
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
initial time when patients are recruited
|
atherosclerosis plaque length 1 in internal carotid artery in milimetre
Временное ограничение: one and a half years after oral appliance treatment
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque length 0 in carotid bolb in milimetre
Временное ограничение: initial time when patients are recruited
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
initial time when patients are recruited
|
atherosclerosis plaque length 1 in carotid bolb in milimetre
Временное ограничение: one and a half years after oral appliance treatment
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
one and a half years after oral appliance treatment
|
breath holding index 0 in percentage/seconds
Временное ограничение: initial time when patients are recruited
|
breath holding index = (v2-v1)/v2*100/t.
v2 is average velocity of middle cerebral artery after breath holding, v1 is average velocity of middle cerebral artery before breath holding, t is time for breath holding.
|
initial time when patients are recruited
|
breath holding index 0 in percentage/seconds
Временное ограничение: one and a half years after oral appliance treatment
|
breath holding index = (v2-v1)/v2*100/t.
v2 is average velocity of middle cerebral artery after breath holding, v1 is average velocity of middle cerebral artery before breath holding, t is time for breath holding.
|
one and a half years after oral appliance treatment
|
End systolic velocity of common carotid artery 0 in cm/s
Временное ограничение: initial time when patients are recruited
|
the velocity of common carotid artery at the end of systolic period
|
initial time when patients are recruited
|
End systolic velocity of common carotid artery 1 in cm/s
Временное ограничение: one and a half years after oral appliance treatment
|
the velocity of common carotid artery at the end of systolic period
|
one and a half years after oral appliance treatment
|
End systolic velocity of internal carotid artery 0 in cm/s
Временное ограничение: initial time when patients are recruited
|
the velocity of internal carotid artery at the end of systolic period
|
initial time when patients are recruited
|
End systolic velocity of internal carotid artery 1 in cm/s
Временное ограничение: one and a half years after oral appliance treatment
|
the velocity of internal carotid artery at the end of systolic period
|
one and a half years after oral appliance treatment
|
End systolic velocity of carotid bulb 0 in cm/s
Временное ограничение: initial time when patients are recruited
|
the velocity of carotid bulb at the end of systolic period
|
initial time when patients are recruited
|
End systolic velocity of carotid bulb 1 in cm/s
Временное ограничение: one and a half years after oral appliance treatment
|
the velocity of carotid bulb at the end of systolic period
|
one and a half years after oral appliance treatment
|
end diastolic velocity of common carotid artery 0 in cm/s
Временное ограничение: initial time when patients are recruited
|
the velocity of common carotid artery at the end of diastolic period
|
initial time when patients are recruited
|
end diastolic velocity of common carotid artery 1 in cm/s
Временное ограничение: one and a half years after oral appliance treatment
|
the velocity of common carotid artery at the end of diastolic period
|
one and a half years after oral appliance treatment
|
end diastolic velocity of internal carotid artery 0 in cm/s
Временное ограничение: initial time when patients are recruited
|
the velocity of internal carotid artery at the end of diastolic period
|
initial time when patients are recruited
|
end diastolic velocity of internal carotid artery 1 in cm/s
Временное ограничение: one and a half years after oral appliance treatment
|
the velocity of internal carotid artery at the end of diastolic period
|
one and a half years after oral appliance treatment
|
end diastolic velocity of carotid bulb 0 in cm/s
Временное ограничение: initial time when patients are recruited
|
the velocity of carotid bulb at the end of diastolic period
|
initial time when patients are recruited
|
end diastolic velocity of carotid bulb 1 in cm/s
Временное ограничение: one and a half years after oral appliance treatment
|
the velocity of carotid bulb at the end of diastolic period
|
one and a half years after oral appliance treatment
|
Соавторы и исследователи
Спонсор
Публикации и полезные ссылки
Общие публикации
- Qin L, Li N, Tong J, Hao Z, Wang L, Zhao Y. Impact of mandibular advancement device therapy on cerebrovascular reactivity in patients with carotid atherosclerosis combined with OSAHS. Sleep Breath. 2021 Sep;25(3):1543-1552. doi: 10.1007/s11325-020-02230-x. Epub 2021 Jan 7.
- Hao Z, Qin L, Tong J, Li N, Zhai Y, Zhao Y. The differences of carotid atherosclerosis among non-OSAHS and OSAHS patients of different severities: a cross-sectional study. Sleep Breath. 2021 Jun;25(2):639-648. doi: 10.1007/s11325-020-02145-7. Epub 2020 Jul 27.
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
- Сердечно-сосудистые заболевания
- Сосудистые заболевания
- Цереброваскулярные расстройства
- Заболевания головного мозга
- Заболевания центральной нервной системы
- Заболевания нервной системы
- Заболевания дыхательных путей
- Артериосклероз
- Артериальные окклюзионные заболевания
- Апноэ
- Нарушения дыхания
- Расстройства сна, внутренние
- Диссомнии
- Расстройства сна и бодрствования
- Инсульт
- Синдромы апноэ во сне
- Ишемический приступ
- Атеросклероз
Другие идентификационные номера исследования
- CSA-Z2015-06
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .
Клинические исследования oral appliance treatment
-
University of SalamancaЗавершенныйСтоматологическая неправильный прикусИспания
-
T.C. ORDU ÜNİVERSİTESİРекрутингКласс II Раздел 1 Неправильный прикусТурция
-
Ain Shams UniversityЗавершенныйСкелетный неправильный прикус
-
Jiayuan SunZhouling (Shanghai) Medical Appliance Co., Ltd.Рекрутинг
-
University of PaviaАктивный, не рекрутирующийГастроэзофагеальный рефлюкс | Стоматологическая эрозияИталия
-
Vanda PharmaceuticalsРекрутингОценка эффектов тазимелтеона у людей с расстройствами аутистического спектра (РАС) и нарушениями снаРасстройство сна | Нарушение сна | Расстройство аутистического спектра | Неврологическое расстройствоСоединенные Штаты
-
University of BrasiliaЗавершенныйЗубной налет | Кариес зубов
-
Mahidol UniversityЗавершенныйСоблюдение, ЛечениеТаиланд
-
Galderma R&DЗавершенныйМорщины | Носогубные складки | Линии марионеток
-
Federal University of the Valleys of Jequitinhonha...ЗавершенныйЗубной налет | Церебральный паралич;Бразилия